Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is abrdn Life Sciences Investors FCF Margin %?
abrdn Life Sciences InvestorsHQL -2.60%51 FCF Margin % is 25.13% as of Mar. 2026, which is 32% below its 10-year median of 36.71. GuruFocus rates HQL with a GF Score™ of 51/100 and a GF Value™ of $62.01 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,451 Asset Management companies, abrdn Life Sciences Investors ranks better than 55.62% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, abrdn Life Sciences Investors's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Life Sciences Investors FCF Margin % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's FCF Margin % distribution charts can be found below:
* The bar in red indicates where abrdn Life Sciences Investors's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Life Sciences Investors (HQL) has a FCF Margin % of 25.13% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on abrdn Life Sciences Investors and its competitors. This is 32% below median its historical median of 36.71. Over the past decade, abrdn Life Sciences Investors' FCF Margin % has ranged from 20.01 to 36.71. According to the industry distribution chart, abrdn Life Sciences Investors ranks #644 out of 1451 companies in the Asset Management industry, placing it in the top 44.4%.
Is abrdn Life Sciences Investors' FCF Margin % too high?
abrdn Life Sciences Investors' current FCF Margin % of 25.13% is 32% below median its 10-year median of 36.71. Over the past 10 years, this metric has ranged from a low of 20.01 to a high of 36.71. The Asset Management industry median FCF Margin % is 12.94. abrdn Life Sciences Investors' value of 25.13% is 94.2% above this industry median. Based on the distribution chart, abrdn Life Sciences Investors ranks #644 out of 1451 companies in the Asset Management industry, which is above the industry midpoint. Overall, abrdn Life Sciences Investors has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does abrdn Life Sciences Investors' FCF Margin % compare to IIM and NOAH?
According to the Asset Management industry distribution chart, abrdn Life Sciences Investors ranks #644 out of 1451 companies for FCF Margin %. This puts abrdn Life Sciences Investors in the upper half of its industry. The industry median FCF Margin % is 12.94. abrdn Life Sciences Investors' value of 25.13% is 94.2% above this benchmark. Historically, abrdn Life Sciences Investors' own FCF Margin % has ranged from 20.01 to 36.71 over the past decade. While the company's 10-year median is 36.71 vs. the industry median of 12.94, abrdn Life Sciences Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for an Asset Management company?
The median FCF Margin % among Asset Management companies is 12.94, based on 1,451 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Life Sciences Investors's current FCF Margin % of 25.13% is 94.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on abrdn Life Sciences Investors and its competitors. For the Asset Management industry, the median FCF Margin % is 12.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Life Sciences Investors's current FCF Margin % is 25.13%, which is 32% below median its own 10-year median of 36.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Life Sciences Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Life Sciences Investors (HQL) is currently considered Significantly Undervalued. The stock's GF Value™ is $62.01, compared to a current price of $22.08 — trading 64.4% below its estimated fair value. The current FCF Margin % is 25.13%, which is 32% below median its 10-year median of 36.71 and 94.2% above the Asset Management industry median of 12.94. abrdn Life Sciences Investors' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For abrdn Life Sciences Investors (HQL), the current FCF Margin % is 25.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Life Sciences Investors (HQL) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Life Sciences Investors stock appears to be undervalued.
The current stock price of $22.08 is trading 64.4% below its estimated GF Value™ of $62.01.
GuruFocus considers abrdn Life Sciences Investors to be Significantly Undervalued.
Key valuation signals for HQL:
FCF Margin %: 25.13% (32% below median its 10-year median of 36.71)
GF Value™: $62.01 vs. price of $22.08 (64.4% below fair value)
Industry Position: 94.2% above the Asset Management median (#644 of 1451)
No single metric tells the full story. See the HQL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
51GF Score
Get the complete analysis for HQL
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQL has been successfully added to your 
